Join the club for FREE to access the whole archive and other member benefits.

John Ramunas

CEO and co-founder of Rejuvenation Technologies Inc

Invented the first safe telomere extension drug, TERT mRNA, patented by Stanford. Invented the simplest pump, patented by Stanford. Co-founded Rejuvenation Technologies to make TERT mRNA-based telomere extension available as broadly and quickly as possible. Experienced founder with a demonstrated history of success, experienced in programming, molecular biology, stem cell biology, animal models, management, mentoring, and drug development. 3 patents, 14 publications, in PNAS, Nature Molecular Therapy, Sensors and Actuators, others. 

Visit website: https://rejuvenationtech.com/Team/

 johnramunas

See also: Company Rejuvenation Technologies - Biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres

Details last updated 04-Sep-2020

John Ramunas News

Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies

Longevity Technology - 07-Sep-2023

A single dose of mRNA therapy could rewind ageing and extend lifespan

Read more...

Telomere extension turns back aging clock in cultured human cells

Stanford University - 22-Jan-2015

Researchers delivered a modified RNA that encodes a telomere-extending protein to cultured human ...

Read more...